Scott Alexander analyzes the potential role of psychopharmacology in the FTX crash, discussing medications used by SBF and others, and their possible effects on decision-making. Longer summary

Scott Alexander discusses the psychopharmacology aspects of the FTX crash, focusing on the medications Sam Bankman-Fried (SBF) and other FTX employees may have been taking. He examines claims about SBF's use of Emsam (selegiline), modafinil, and other stimulants, explaining their effects and potential risks. Scott also critiques the actions of FTX's company psychiatrist and discusses the broader implications of stimulant use in high-pressure work environments. The post ends with Scott's personal anecdote about testifying as an expert witness. Shorter summary

Scott Alexander analyzes a study showing Concerta improves ADHD children's attention but not their learning, and speculates on the reasons behind this unexpected result. Longer summary

Scott Alexander discusses a recent study on the effects of Concerta (a long-acting form of Ritalin) on ADHD children's learning in a summer camp setting. The study found that while Concerta improved attention, reduced disruptive behavior, and slightly improved test scores, it didn't significantly enhance learning of the course material. Scott explores potential reasons for this counterintuitive result, drawing parallels to other studies and speculating on the nature of learning and intelligence. He considers factors such as redundancy in teaching, innate intelligence limits, and the possibility of 'difficulty thresholds' for learning. The post ends with a speculative comparison to AI scaling laws, suggesting there might be human equivalents to parameters, training data, and compute in learning. Shorter summary

Scott examines the possibility that bureaucracy sometimes serves as an intentional barrier to discourage unnecessary requests, particularly in healthcare, but questions how widely this concept applies. Longer summary

This post explores the idea that bureaucracy might sometimes serve as an active ingredient in plans rather than just being inefficient. Scott presents a hypothetical scenario where insurance companies use bureaucratic hurdles to discourage unnecessary use of expensive medications. He suggests that the time and effort required to navigate bureaucracy can act as a filter, separating those who truly need a service from those who don't. However, Scott expresses uncertainty about how widely this concept applies, noting that it doesn't explain bureaucracy in places like the DMV. He concludes that while this idea might explain some instances of bureaucracy, particularly in healthcare, it shouldn't be overgeneralized. Shorter summary

Scott Alexander examines the risks of Adderall use, analyzing medical, addiction, tolerance, and neurotoxicity concerns, concluding that the benefits outweigh the risks for well-informed patients. Longer summary

Scott Alexander explores the risks of Adderall use, examining medical risks, addiction potential, tolerance development, and possible neurotoxicity. He critically analyzes existing research and shares his clinical experience, ultimately concluding that while there are some concerning risks, they are not severe enough to stop prescribing stimulants to patients who might benefit from them, provided they are well-informed about the risks. Shorter summary